Bharat Biotech International Ltd has initiated clinical trials for the Tuberculosis vaccine MTBVAC on adults in India.
- MTBVAC is the first tuberculosis vaccine derived from a human source, developed by the Spanish bio-pharmaceutical company, Biofabri.
- Bharat Biotech is conducting these trials in close collaboration with Biofabri.
- The clinical trials involve a dose escalation trial in HIV-uninfected adults, followed by a Phase 2 study in HIV-infected adults to assess the safety of MTBVAC in this population.
- The development of MTBVAC is seen as a significant milestone in global vaccinology, highlighting the importance of public-private, national, and international collaboration.
Q: Which company has initiated clinical trials for the Tuberculosis vaccine MTBVAC on adults in India?
a) Biofabri
b) Bharat Biotech International Ltd
c) Spanish bio-pharmaceutical company
d) Global Vaccinology Collaboration
Ans : b) Bharat Biotech International Ltd
